A Study to Evaluate the Food Effects on Pharmacokinetics of SY-5007 Tablets in Healthy Subjects

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

May 1, 2024

Study Completion Date

May 1, 2024

Conditions
Health Subjects
Interventions
DRUG

SY-5007

SY-5007 160 mg, Tablets, 2 discrete single doses separated by 7-days

DRUG

SY-5007

SY-5007 160 mg, Tablets, 2 discrete single doses separated by 7-days

Trial Locations (1)

610041

West China Hospital of Sichuan University, Chengdu

All Listed Sponsors
lead

Shouyao Holdings (Beijing) Co. LTD

OTHER